The Australian Society of Ophthalmologists (ASO) announces the appointment of Katrina Ronne as its first woman chief ...

Researchers set out to determine the age groups for which a polygenic risk score would most effectively predict glaucomatous ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the ...

The findings were from 6 patients in the first low-dose cohort of the ongoing first-in-human trial (NCT04627428).

The US Food and Drug Administration (FDA) has approved revakinagene taroretcel-lwey (ENCELTO) from Neurotech Pharmaceuticals ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

At the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma ...

Researchers conducted a first-of-a-kind cross-sectional study at the outpatient clinic of the Eye Hospital of China Academy ...

Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging ...